採用
必須スキル
Market Access
Pharmacy Market Access
Negotiation
Stakeholder Management
French
English
About the Role
IQVIA is expanding its team and is seeking a Market Access and Public Affairs Manager based in France. This is one of several newly created roles across the EU due to our customers' ongoing success, and ahead of product launches in 2026. Our customer is a global biopharmaceutical company, dedicated to bringing biosimilar medicines to market, ensuring high-quality biologics are available to more patients at cost effective prices. Since their inception they have developed the industry's most rapidly advancing biosimilar medicines portfolio and become leaders in this field. This is a fantastic opportunity to contribute to the market access strategy in a company which operates in diverse, highly specialist therapy areas and which continues to demonstrate significant growth.
Responsibilities
- Meet and exceed country sales target while supporting the wider commercial team in achieving their objectives
- Develop and execute a country-wide market access plan in collaboration with the Country Manager and EU Tender Department to ensure portfolio availability
- Drive commercial success for biosimilars in the retail pharmacy market by negotiating, partnering, and influencing key stakeholders across the distribution and retail ecosystem
- Map, engage, and build strong relationships with key stakeholders, including wholesalers, pharmacy groups (VTOs), GPO buyers, payers, policy makers, trade organizations, and KOLs
- Lead negotiations with wholesalers and pharmacy networks to secure product listings, agreements, and optimal distribution channel inclusion
- Identify new business opportunities and prepare business cases to maximize local value
- Build and strengthen strategic partnerships that support product adoption and competitive positioning, including contributing to substitution strategies for biosimilars
- Monitor market dynamics, competitor activities, and regulatory developments to inform strategy and maintain competitive advantage
- Support advocacy and policy initiatives to promote the value, sustainability, and wider adoption of biosimilars
Qualifications and Experience Required
- Scientific degree (PhD, PharmD, MD, MSc, etc.)
- Proven background in retail market access / pharmacy market access
- Proven track record in companies marketing biosimilars, generics, or substitutable prescription products
- Hands-on experience negotiating with wholesalers, pharmacy groups (VTOs), and retail distribution networks
- Demonstrable success in product launches in the retail sector, with a full understanding of the value chain
- Strong knowledge of French regulatory framework around pricing, rebates, and commercial conditions for prescription drugs
- Strategic vision with a medium to long-term perspective on retail market evolution
- Political acumen and ability to navigate complex regulatory environments
- Experience in advocacy and policy shaping to support biosimilar adoption
- Excellent time management, organization skills, and ability to prioritize multiple projects
- Fluency in French with strong verbal, written and interpersonal skills; English language ability would be highly desirable
Additional Information
Please apply in English. IQVIA is working on behalf of our partners in France.
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at https://jobs.iqvia.com
IQVIA is committed to integrity in our hiring process and maintains a zero tolerance policy for candidate fraud. All information and credentials submitted in your application must be truthful and complete. Any false statements, misrepresentations, or material omissions during the recruitment process will result in immediate disqualification of your application, or termination of employment if discovered later, in accordance with applicable law. We appreciate your honesty and professionalism.
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create connections that accelerate the development and commercialization of innovative medical treatments. Everything we do is part of a journey to improve patient outcomes and population health worldwide. To get there, we seek out diverse talent with curious minds and a relentless commitment to innovation and impact. No matter your role, everyone at IQVIA contributes to our shared goal of helping customers improve the lives of patients everywhere. Thank you for your interest in growing your career with us.
総閲覧数
0
応募クリック数
0
模擬応募者数
0
スクラップ
0
類似の求人
IQVIAについて

IQVIA
PublicIQVIA Holdings, Inc. is an American company based in Durham, North Carolina, focused on health information technology and clinical research.
10,001+
従業員数
Durham
本社所在地
$17B
企業価値
レビュー
3.6
10件のレビュー
ワークライフバランス
3.8
報酬
2.5
企業文化
4.0
キャリア
3.2
経営陣
2.8
65%
友人に勧める
良い点
Good work-life balance
Supportive team and collaborative environment
Flexible hours and good benefits
改善点
Compensation below industry standards
High workload and overwhelming at times
Poor management communication and organization
給与レンジ
51件のデータ
Mid/L4
Director
Mid/L4 · CLIENT OPERATIONS LEAD
2件のレポート
$114,000
年収総額
基本給
$91,012
ストック
-
ボーナス
-
$114,000
$114,000
面接体験
3件の面接
難易度
3.0
/ 5
期間
14-28週間
体験
ポジティブ 0%
普通 33%
ネガティブ 67%
面接プロセス
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Technical Manager Interview
5
Executive/GM Interview
6
Offer
よくある質問
Behavioral/STAR
Case Study
Technical Knowledge
Past Experience
Culture Fit
ニュース&話題
Whittier Trust Co. Has $4.04 Million Stake in IQVIA Holdings Inc. $IQV - MarketBeat
MarketBeat
News
·
3d ago
IQVIA Holdings stock (US46266C1053): Is its data-driven healthcare edge strong enough to unlock new - AD HOC NEWS
AD HOC NEWS
News
·
3d ago
IQVIA.ai Launch With NVIDIA Puts IQVIA’s AI Valuation In Focus - Yahoo Finance
Yahoo Finance
News
·
5d ago
Is It Time To Reconsider IQVIA (IQV) After This Year’s 23.7% Share Price Decline - simplywall.st
simplywall.st
News
·
5d ago




